TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Haemostasis AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 145 | 185 | 129 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 2 | 75 | 6 |
EBITDA | 2 | 75 | 6 |
Total assets | 78 | 102 | 59 |
Current assets | 71 | 102 | 59 |
Current liabilities | 12 | 27 | 27 |
Equity capital | 65 | 75 | 32 |
- share capital | 4 | 5 | 5 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 83.3% | 73.5% | 54.2% |
Turnover per employee | 72 | 92 | 64 |
Profit as a percentage of turnover | 1.4% | 40.5% | 4.7% |
Return on assets (ROA) | 2.6% | 73.5% | 10.2% |
Current ratio | 591.7% | 377.8% | 218.5% |
Return on equity (ROE) | 3.1% | 100% | 18.8% |
Change turnover | -25 | 58 | -1 |
Change turnover % | -15% | 46% | 0% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.